Elevance Enters Joint Development Agreement with Stepan to Commercialize Novel Surfactants & Antimicrobials
Elevance announced yesterday it entered into a joint development agreement with Stepan Company to evaluate and commercialize novel surfactants, antimicrobials and polyurethane polyols based on Elevance’s specialty feedstocks, including 9-decenoic ester and C18 di-basic ester.
Stepan’s joint development with Elevance represents a significant opportunity for both companies. It brings together complimentary capabilities and will accelerate development of high value specialty products needed in markets targeted by both companies.
Our business model is one of partnerships. We have established them in technology, feedstocks, manufacturing and markets. Each of these collaborations (whether publicly announced or still confidential) is creating opportunity for our partner in addition to helping to transforming the petrochemical industry to sustainable, renewable based products.
We are pleased to be working with Stepan to deliver value to their customers and achieve growth through innovation.